153 related articles for article (PubMed ID: 25845564)
1. Heymann nephritis in Lewis rats.
Wang YM; Lee VWS; Wu H; Harris DCH; Alexander SI
Curr Protoc Immunol; 2015 Apr; 109():15.29.1-15.29.6. PubMed ID: 25845564
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody.
Hasegawa Y; Kaneoka H; Tanaka T; Ogahara S; Matsumae T; Noda R; Yoshitake K; Murata T; Naito S
Nephron; 2001 Jul; 88(3):233-40. PubMed ID: 11423754
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
4. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.
Schiller B; He C; Salant DJ; Lim A; Alexander JJ; Quigg RJ
J Exp Med; 1998 Oct; 188(7):1353-8. PubMed ID: 9763614
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies.
Wu H; Walters G; Knight JF; Alexander SI
J Immunol; 2003 Nov; 171(9):4824-9. PubMed ID: 14568961
[TBL] [Abstract][Full Text] [Related]
7. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
Huang J; Makker SP
Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
[TBL] [Abstract][Full Text] [Related]
8. Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells.
Spicer ST; Ha H; Boyd RA; He XY; Carter N; Tran G; Penny MJ; Hodgkinson SJ; Hall BM
J Immunol; 2001 Oct; 167(7):3725-33. PubMed ID: 11564788
[TBL] [Abstract][Full Text] [Related]
9. Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli.
Penny MJ; Boyd RA; Hall BM
Kidney Int; 1997 Apr; 51(4):1059-68. PubMed ID: 9083271
[TBL] [Abstract][Full Text] [Related]
10. Experimental membranous glomerulonephritis in rats induced with gp 700, a glomerular protein.
Kamata K; Sato N; Horata E; Kobayashi Y; Okubo M
Int Immunol; 1990; 2(11):1013-20. PubMed ID: 1707302
[TBL] [Abstract][Full Text] [Related]
11. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
Natori Y; Hayakawa I; Shibata S
Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
[TBL] [Abstract][Full Text] [Related]
12. Induction of Heymann nephritis with a gp330/megalin fusion protein.
Raychowdhury R; Zheng G; Brown D; McCluskey RT
Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition.
Penny MJ; Boyd RA; Hall BM
J Am Soc Nephrol; 1998 Dec; 9(12):2272-82. PubMed ID: 9848781
[TBL] [Abstract][Full Text] [Related]
14. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
Farquhar MG; Saito A; Kerjaschki D; Orlando RA
J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
[TBL] [Abstract][Full Text] [Related]
15. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
Orlando RA; Kerjaschki D; Farquhar MG
J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the pathogenic roles of antigens isolated from renal tubular cells in the classical Heymann nephritis].
Yamagata K; Koyama A; Kobayashi M; Narita M
Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1053-60. PubMed ID: 2287097
[TBL] [Abstract][Full Text] [Related]
17. Characterization of antigens and antibody specificities involved in Heymann nephritis.
Kamata K; Baird LG; Erikson ME; Collins AB; McCluskey RT
J Immunol; 1985 Oct; 135(4):2400-8. PubMed ID: 2411795
[TBL] [Abstract][Full Text] [Related]
18. Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities.
Natori Y; Hayakawa I; Shibata S
Clin Exp Immunol; 1987 Jul; 69(1):33-40. PubMed ID: 2443290
[TBL] [Abstract][Full Text] [Related]
19. Detection of two forms of GP330. Their role in Heymann nephritis.
Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
Kerjaschki D; Farquhar MG
J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
